Key facts
- This page summarizes Kameel D. Farag's Form 4 filing for Akari Therapeutics Plc (AKTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2026, 17:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on September 15, 2026.